Mattson KV - Search Results

1

Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer--a randomised study.

Halme M, Maasilta PK, Pyrhönen SO, Mattson KV. Halme M, et al. Among authors: mattson kv. Eur J Cancer. 1994;30A(1):11-5. doi: 10.1016/s0959-8049(05)80009-7. Eur J Cancer. 1994. PMID: 8142151 Clinical Trial.

2

Inhaled recombinant interferon gamma in patients with lung cancer: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes.

Halme M, Maasilta P, Repo H, Ristola M, Taskinen E, Mattson K, Cantell K. Halme M, et al. Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):93-101. doi: 10.1016/0360-3016(94)00365-R. Int J Radiat Oncol Biol Phys. 1995. PMID: 7995773 Clinical Trial.

3

Pharmacokinetics and toxicity of inhaled human natural interferon-beta in patients with lung cancer.

Halme M, Maasilta P, Mattson K, Cantell K. Halme M, et al. Respiration. 1994;61(2):105-7. doi: 10.1159/000196316. Respiration. 1994. PMID: 8008985

4

Subcutaneously administered recombinant interferon-gamma in humans: pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages, blood neutrophils, and monocytes.

Halme M, Maasilta P, Repo H, Leirisalo-Repo M, Taskinen E, Mattson K, Cantell K. Halme M, et al. J Immunother Emphasis Tumor Immunol. 1994 May;15(4):283-91. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8061901 Clinical Trial.

5

Bronchoalveolar lavage fluid findings following radiotherapy for non-small cell lung cancer.

Maasilta P, Hallman M, Taskinen E, Kivisaari L, Mattson K. Maasilta P, et al. Int J Radiat Oncol Biol Phys. 1993 Apr 30;26(1):117-23. doi: 10.1016/0360-3016(93)90181-t. Int J Radiat Oncol Biol Phys. 1993. PMID: 8387063

6

Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.

Hand A, Pelin K, Halme M, Ekman A, Mattson M, Vallas M, Mattson K, Linnainmaa K, Husgafvel-Pursiainen K. Hand A, et al. Anticancer Drugs. 1993 Jun;4(3):365-8. Anticancer Drugs. 1993. PMID: 8395259

7

A phase II trial of docetaxel in advanced non-small cell lung cancer.

Saarinen A, Jekunen A, Halme M, Pyrhönen S, Tamminen K, Boyer R, Roubille N, Mattson K. Saarinen A, et al. Anticancer Drugs. 1996 Nov;7(8):890-2. doi: 10.1097/00001813-199611000-00012. Anticancer Drugs. 1996. PMID: 8991195 Clinical Trial.

8

Interferon maintenance therapy for small cell lung cancer: improvement in long-term survival.

Mattson K, Niiranen A, Ruotsalainen T, Maasilta P, Halme M, Pyrhönen S, Kajanti M, Mäntylä M, Tamminen K, Jekunen A, Sarna S, Cantell K. Mattson K, et al. J Interferon Cytokine Res. 1997 Feb;17(2):103-5. doi: 10.1089/jir.1997.17.103. J Interferon Cytokine Res. 1997. PMID: 9058316 Clinical Trial.

9

Phase II study of weekly gemcitabine in advanced non-small cell lung cancer.

Halme M, Jekunen A, Tamminen K, Mattson K. Halme M, et al. Respir Med. 1997 Aug;91(7):423-6. doi: 10.1016/s0954-6111(97)90257-2. Respir Med. 1997. PMID: 9327044 Free article. Clinical Trial.

10

Paclitaxel (Taxol) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLC.

Isokangas OP, Joensuu H, Halme M, Jekunen A, Mattson K. Isokangas OP, et al. Lung Cancer. 1998 May;20(2):127-33. doi: 10.1016/s0169-5002(98)00025-7. Lung Cancer. 1998. PMID: 9711531 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters